In patients with DCIS, the sentinel lymph node (LN) anti-HER2 CD4+ T cell response rather than peripheral blood anti-HER2 CD4+ or CD8+ T cell immune response was associated with pCR (47). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.